Promimic
18.95
SEK
+5.57 %
Less than 1K followers
PRO
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Ownership
Investor consensus
+5.57%
-21.69%
-32.32%
-15.78%
-34.66%
-42.23%
+36.82%
-
+16.39%
Promimic specializes in biotechnology. The company conducts research and development in surface modifications. Examples of specialist areas include surface modifications for osseointegration for orthopedic and dental implants. The main operations are in Europe and America, where research and development are conducted in-house but also through partners.
Read moreMarket cap
358.01M SEK
Turnover
3.9K SEK
Revenue
43.98M
EBIT %
-18.92 %
P/E
-
Dividend yield-%
-
Financial calendar
22/8
2025
Interim report Q2'25
19/11
2025
Interim report Q3'25
24/2
2026
Annual report '25
All
Press releases
ShowingAll content types
Promimic AB: Strategiska affärer för tillväxt i Kvartal 1 2025
Promimic AB: Fördjupat samarbete med Curiteva
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools